About Allucent (India) Private Limited
Data last updated:
Allucent (India) Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Allucent (Uk) Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 27 November 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51397KA2002PTC031282. Its GSTIN is 29AACCP8216E1ZF (Karnataka). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Pharm-Olam International (India) Private Limited. It is led by directors Sivakumar Subramanian and Howard Richard Brand.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.87 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹3.22 Cr (net margin 6.7%) and EBITDA of ₹6.18 Cr (EBITDA margin 12.9%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 27% over five years.
The company has about 177 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Pharm-Olam and Allucent.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website allucent.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressUnit No. 602 6th Floor Rmz Ecoworld Campus 31, Sarjapur Marathahalli Orr Devarabeesanahalli Village Varthur Hobli, Bangalore, Karnataka, India – 560103
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Allucent (India) Private Limited
The main business activity of Allucent (India) is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Allucent (India) Private Limited FY 2024 filings available
Allucent (India) Private Limited reported revenue of ₹47.87 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Allucent (India) Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 4% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Allucent (India) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.18 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.22 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Allucent (India) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Allucent (India) are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Allucent (India) Private Limited
Allucent (India) Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Premier Research Group (India) Private Limited | ₹54.7 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Bengaluru, Karnataka, India |
| Alvogen Pharma (India) Private Limited | ₹51.32 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Bangalore, Karnataka, India |
| Norwich Clinical Services Private Limited | ₹51.26 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Bangalore, Karnataka, India |
| Spark Scientific Private Limited | ₹50.71 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Hyderabad, Telangana, India |
| Opes Health Care Private Limited | ₹50.42 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Ahmedabad, Gujarat, India |
| Allucent (India) Private Limited this company | ₹47.87 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Bangalore, Karnataka, India |
| Jeevan Scientific Technology Limited Listed | ₹47.5 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Hyderabad, Telangana, India |
| Emerald Clinical Trials India Private Limited | ₹46.42 Cr (FY 2025) | •••• | •••• | -28.0% | •••• | Bangalore, Karnataka, India |
| Premas Biotech Private Limited | ₹45.93 Cr (FY 2025) | •••• | •••• | 65.0% | •••• | Manesar, Haryana, India |
| Vivo Bio Tech Limited Listed | ₹45.49 Cr (FY 2024) | •••• | •••• | -13.0% | •••• | Hyderabad, Telangana, India |
| Intox Private Limited | ₹45.44 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Mulshi, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Allucent (India) by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Allucent (India) Private Limited
Allucent (India) Private Limited is audited by Vasan & Sampath LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Vasan & Sampath LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Allucent (India) Private Limited
Allucent (India) has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sivakumar Subramanian | Director | 21 Feb 2023 | 3 Years 7 Months | Current |
| Howard Richard Brand | Additional Director | 29 Sep 2025 | 1 Years 0 Months | Current |
Ownership and Shareholding of Allucent (India) Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Allucent (India) Private Limited
Allucent (India) Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Allucent (India) Private Limited
Allucent (India) operates two associated brands: Pharm-Olam and Allucent. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Full-service CRO operations are conducted in over 60 countries. | pharm-olam.com | |
| Allucent is recognized as a global contract research organization supporting biotech companies. | allucent.com |
Employees and EPFO Compliance at Allucent (India) Private Limited
Allucent (India) Private Limited has a workforce of 177 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Allucent (India) Private Limited
Allucent (India) Private Limited has 13 board changes on record since 2009: 3 appointments and 10 cessations. The latest: Howard Richard Brand was appointed as Additional Director on 29 Sep 2025.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Allucent (India) Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Allucent (India) Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Allucent (India) Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Allucent (India) Private Limited
Allucent (India) has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCP8216E1ZF | Karnataka | Active | 01 Jul 2017 |
| 33AACCP8216E1ZQ | Tamil Nadu | Active | 19 May 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Allucent (India) Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Allucent (India) Private Limited
Allucent (India) is an active private limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 27 November 2002 (24+ years old) and is registered under CIN U51397KA2002PTC031282.
Allucent (India) reported revenue of ₹47.87 Cr for FY 2025 (up 4% YoY).
Allucent (India) has 2 current directors:
- Sivakumar Subramanian - Director
- Howard Richard Brand - Additional Director
Allucent (India) reported a net profit of ₹3.22 Cr (net margin 6.7%) and EBITDA of ₹6.18 Cr (EBITDA margin 12.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Allucent (India) is 33% over three years and 27% over five years. In the latest year (FY 2025) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Allucent (India) is 29AACCP8216E1ZF, registered in Karnataka. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 33AACCP8216E1ZQ (Tamil Nadu).
The CIN (Corporate Identification Number) of Allucent (India) is U51397KA2002PTC031282. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Allucent (India) was incorporated on 27 November 2002, making it 24+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Allucent (India) by revenue are Premier Research Group (India) Private Limited, Alvogen Pharma (India) Private Limited, Norwich Clinical Services Private Limited, Spark Scientific Private Limited, Opes Health Care Private Limited and 5 more, all in the Pharma industry (Contract Research).
Howard Richard Brand was appointed as Additional Director on 29 Sep 2025. Sivakumar Subramanian ceased to be Additional Director on 28 Dec 2023. Sivakumar Subramanian ceased to be Additional Director on 28 Sep 2023. Allucent (India) has 13 board changes on record in total.
Allucent (India) can be reached through the website allucent.com. Its registered office is in Bangalore, Karnataka, India.